Biodegradable Polymer Coated Emodin Eluting Stent in vitro and in vivo

Yan-chao ZHAO,Fei-rong GONG,Jun-bo GE,Shu-jun CHENG,Jian-ding CHEN
DOI: https://doi.org/10.14135/j.cnki.1006-3080.2008.02.024
2008-01-01
Abstract:Heparinizing copolymer of L-lactide and (3S)-3-[(Benzyl oxycarbonyl) methyl] morpholine-2, 5-dione mixed with emodin as delivered drug was applied to the bare metal stents with self-made spry instrument to prepare the emodin eluting stents (Emodin (150 ± 5)μg). Emodin released from the stent was investigated in PBS at (37 ± 0.5)°C. The in vivo experiments were proceeded from 1 to 3 months with polymer coating stent and bare metal stent as the control groups. SEM images showed that the surfaces of expanded emodin eluting stents were crackless. In addition, the in vitro release investigation indicated 90% of emodin had been released within 10 days in terms of drug-eluting stents with high emodin content coating (Emodin 50%). According to the in vivo experiments in pigs, the coating degraded almost entirely in 3 months. The results of section pictures and neointimal thickness show emodin could suppress the neointimal hyperplasia and the restenosis effectively.
What problem does this paper attempt to address?